Comments
Loading...

Sigyn Therapeutics Analyst Ratings

SIGYOTCQB
Logo brought to you by Benzinga Data
$3.53
-0.62-14.94%
At close: -

Sigyn Therapeutics Analyst Ratings and Price Targets | OTC:SIGY | Benzinga

Sigyn Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Sigyn Therapeutics Corp from these most-recent analyst ratings.

Analyst Ratings for Sigyn Therapeutics

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Sigyn Therapeutics (SIGY) stock?

A

There is no price target for Sigyn Therapeutics

Q

What is the most recent analyst rating for Sigyn Therapeutics (SIGY)?

A

There is no analyst for Sigyn Therapeutics

Q

When was the last upgrade for Sigyn Therapeutics (SIGY)?

A

There is no last upgrade for Sigyn Therapeutics

Q

When was the last downgrade for Sigyn Therapeutics (SIGY)?

A

There is no last downgrade for Sigyn Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Sigyn Therapeutics (SIGY)?

A

There is no next analyst rating for Sigyn Therapeutics.

Q

Is the Analyst Rating Sigyn Therapeutics (SIGY) correct?

A

There is no next analyst rating for Sigyn Therapeutics.

Browse analyst ratings and price targets on all stocks.